Safe and hugely efficient vaccines can be obtained for two viral STIs: hepatitis B and HPV. These vaccines have represented important improvements in STI avoidance. By the top of 2023, the HPV vaccine had been launched as Component of routine immunization programmes in 140countries, largely high- and middle-cash flow countries. https://us.hc6.org/